These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11546957)

  • 21. [Urinary lithiasis secondary to indinavir in an HIV-positive patient].
    Moyano Calvo JL; Huesa Martínez I; Cruz Navarro N; Leal Arenas J; León Dueñas E; Morales López A; Maestro Durán JL; Ramírez Mendoza A
    Arch Esp Urol; 2001 Dec; 54(10):1117-20. PubMed ID: 11852520
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute tubulointerstitial nephritis attributable to indinavir therapy.
    Jaradat M; Phillips C; Yum MN; Cushing H; Moe S
    Am J Kidney Dis; 2000 Apr; 35(4):E16. PubMed ID: 10739809
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors for indinavir-related renal colic in HIV patients: predictive value of indinavir dose/body mass index.
    Meraviglia P; Angeli E; Del Sorbo F; Rombolà G; Viganò P; Orlando G; Cordier L; Faggion I; Cargnel A
    AIDS; 2002 Oct; 16(15):2089-93. PubMed ID: 12370513
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is indinavir crystalluria an indicator for indinavir stone formation?
    Salahuddin S; Hsu YS; Buchholz NP; Dieleman JP; Gyssens IC; Kok DJ
    AIDS; 2001 May; 15(8):1079-80. PubMed ID: 11400000
    [No Abstract]   [Full Text] [Related]  

  • 25. Persistent nephrolithiasis after discontinuation of indinavir therapy.
    Polhemus ME; Aronson NE
    Clin Infect Dis; 1998 Dec; 27(6):1536-7. PubMed ID: 9868678
    [No Abstract]   [Full Text] [Related]  

  • 26. Renal atrophy associated with long-term treatment with indinavir.
    Hanabusa H; Tagami H; Hataya H
    N Engl J Med; 1999 Feb; 340(5):392-3. PubMed ID: 9988612
    [No Abstract]   [Full Text] [Related]  

  • 27. Urolithiasis associated with the protease inhibitor indinavir.
    Bruce RG; Munch LC; Hoven AD; Jerauld RS; Greenburg R; Porter WH; Rutter PW
    Urology; 1997 Oct; 50(4):513-8. PubMed ID: 9338724
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Persistent sterile leukocyturia is associated with impaired renal function in human immunodeficiency virus type 1-infected children treated with indinavir.
    van Rossum AM; Dieleman JP; Fraaij PL; Cransberg K; Hartwig NG; Burger DM; Gyssens IC; de Groot R
    Pediatrics; 2002 Aug; 110(2 Pt 1):e19. PubMed ID: 12165618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Symptomatic crystalluria associated with indinavir.
    Famularo G; Di Toro S; Moretti S; De Simone C
    Ann Pharmacother; 2000 Dec; 34(12):1414-8. PubMed ID: 11144699
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pyuria in patients treated with indinavir is associated with renal dysfunction.
    Sarcletti M; Petter A; Romani N; Lhotta K; König P; Maier H; Zangerle R
    Clin Nephrol; 2000 Oct; 54(4):261-70. PubMed ID: 11076101
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Indinavir crystallization and urolithiasis.
    Grases F; Costa-Bauzá A; García-González R; Payeras A; Bassa A; Torres JJ; Conte A
    Int Urol Nephrol; 1999; 31(1):23-9. PubMed ID: 10408298
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A side effect of protease inhibitors.
    Teitel J
    CMAJ; 1998 May; 158(9):1129-30. PubMed ID: 9597957
    [No Abstract]   [Full Text] [Related]  

  • 33. Subtle occurrence of indinavir-induced acute renal insufficiency.
    Viganò A; Rombolà G; Barbiano di Belgioioso G; Sala N; Principi N
    AIDS; 1998 May; 12(8):954-5. PubMed ID: 9631152
    [No Abstract]   [Full Text] [Related]  

  • 34. [Indinavir and renal lithiasis].
    Traba Villameytide ML; Fernández-Guerrero M
    Actas Urol Esp; 2004; 28(7):523-6. PubMed ID: 15384277
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Crystalluria and urinary tract abnormalities associated with indinavir.
    Kopp JB; Miller KD; Mican JA; Feuerstein IM; Vaughan E; Baker C; Pannell LK; Falloon J
    Ann Intern Med; 1997 Jul; 127(2):119-25. PubMed ID: 9230000
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A phase I/II study of the protease inhibitor indinavir in children with HIV infection.
    Mueller BU; Sleasman J; Nelson RP; Smith S; Deutsch PJ; Ju W; Steinberg SM; Balis FM; Jarosinski PF; Brouwers P; Mistry G; Winchell G; Zwerski S; Sei S; Wood LV; Zeichner S; Pizzo PA
    Pediatrics; 1998 Jul; 102(1 Pt 1):101-9. PubMed ID: 9651421
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Indinavir-induced renal failure.
    Chen SC; Nankivell BJ; Dwyer DE
    AIDS; 1998 Mar; 12(4):440-1. PubMed ID: 9520176
    [No Abstract]   [Full Text] [Related]  

  • 38. Nonopaque crystal deposition causing ureteric obstruction in patients with HIV undergoing indinavir therapy.
    Blake SP; McNicholas MM; Raptopoulos V
    AJR Am J Roentgenol; 1998 Sep; 171(3):717-20. PubMed ID: 9725303
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Indinavir/low-dose ritonavir containing HAART in HIV-1 infected children has potent antiretroviral activity, but is associated with side effects and frequent discontinuation of treatment.
    Fraaij PL; Verweel G; van Rossum AM; Hartwig NG; Burger DM; de Groot R
    Infection; 2007 Jun; 35(3):186-9. PubMed ID: 17565462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renal toxicity of protease inhibitors.
    Olyaei AJ; deMattos AM; Bennett WM
    Curr Opin Nephrol Hypertens; 2000 Sep; 9(5):473-6. PubMed ID: 10990364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.